Mepolizumab is an interleukin-5 antagonist monoclonal antibody (IgG1 kappa) for the add-on maintenance treatment of severe asthma patients aged 12 years and older and with an eosinophilic phenotype <a id="
Localización de Nuestra Oficina principal:
Dirección Física:
1441 F.D. Roosevelt Ave.
San Juan, P.R. 00936
Dirección Postal:
P.O. Box 363628
San Juan, P.R. 00936-3628